Implementing Monoclonal Antibodies for Treatment and Prevention in Resource-Limited Settings - How to Make Them Affordable - Dr. Ripin

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

How Will Technology Evolve: Delivery Methods and Formulations - Dr. Appel

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

How Will Technology Evolve: Modification of Antibodies - Dr. Juelg

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibody Dosing in Pediatrics: Rational Basis and Examples - Dr. Meibohm

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

How to Determine the Dosing (in Different Populations/Tissues) - Dr. Capparelli

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies for Treatment in Hematologic Malignancies - Dr. Moskowitz

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies for Treatment in Autoimmune Diseases - Dr. Chan

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Dr, Cohen

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies for Treatment in HIV - Dr. Caskey

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies for Treatment in COVID-19 - Prof. Ader

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Screening Technologies & Platforms - Dr. Robbiani

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Monoclonal Antibodies Against COVID-19: Targets, Development and Clinical Applications - Prof. Autran

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Historical Perspectives from Pasteur to Flexner: The Evolution of Serum to Monoclonal Antibody Therapy - Prof. Flexner

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Roundtable Discussion Session 2 - Approaches to Combat COVID-19 in Low- and Middle-Income Countries

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

Roundtable Discussion Session 1 - Approaches to Combat COVID-19 in Low- and Middle Income Countries

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

Use of COVID-19 Therapeutic Options Accessible in LMIC for ... - Brenda Crabtree Ramirez, MD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

Surveillance and Public Health Measures for LMICs - Waasila Jassat, MBBCh, MMed, FCPHM

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

Diagnostic Challenges in LMICs - Rosanna Peeling, PhD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

Vaccinating as Fast as Possible – Challenges for LMICs - Claudia Cortes, MD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

Preparing the Global Health System – What Are the Considerations? - Michel Kazatchkine, MD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

The Impact of COVID-19 on Global Health Burden - Christian Brechot, MD, PhD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

Clinical Respiratory Management in LMICs - Ary Serpa Neto, MD MSc PhD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

Acute COVID-19 and Predictors of Outcome - Lloyd Mulenga, BScHb, MBChB, MSc, MMed, PhD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

Sorting Out Respiratory Illnesses - Sanjat Kanjilal, MD, MPH

COVID-19 Clinical Management Workshop 2021